Howard Kim

About the Author Howard Kim


Analysts Are Bullish on These Technology Stocks: Airbus Group SE (EADSF), Microsoft (MSFT)

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Airbus Group SE (EADSF), Microsoft …

Sierra Oncology (SRRA) Gets a Buy Rating from Oppenheimer

Oppenheimer analyst Jay Olson maintained a Buy rating on Sierra Oncology (SRRA) today and set a price target of $29.00.

Goldman Sachs Believes Eli Lilly & Co (LLY) Won’t Stop Here

Goldman Sachs analyst Terence Flynn maintained a Buy rating on Eli Lilly & Co (LLY) today and set a price target of $270.00.

Needham Issues a Buy Rating on Resmed (RMD)

In a report released today, Michael Matson from Needham assigned a Buy rating to Resmed (RMD), with a price target of $229.00.

BiomX (PHGE) Gets a Buy Rating from H.C. Wainwright

In a report released today, Joseph Pantginis from H.C.

Analysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Forma Therapeutics Holdings (FMTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biogen (BIIB), Forma Therapeutics Holdings …

Oppenheimer Releases a Hold Rating on Sabre (SABR)

In a report released today, Jed Kelly from Oppenheimer assigned a Hold rating to Sabre (SABR). The company’s shares closed last Friday at …

Oppenheimer Thinks Aptose Biosciences’ Stock is Going to Recover

In a report released today, Matthew Biegler from Oppenheimer maintained a Buy rating on Aptose Biosciences (APTO), with a price target of $9.00.

Medallia (MDLA) Received its Third Buy in a Row

After Oppenheimer and Craig-Hallum gave Medallia (NYSE: MDLA) a Buy rating last month, the company received another Buy, this time from Needham. Analyst …

H.C. Wainwright Thinks Equillium’s Stock is Going to Recover

In a report released today, Ram Selvaraju from H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts